Literature DB >> 22383459

Does passive smoking have an effect on nasal mucociliary clearance?

Mehmet Habesoglu1, Kadri Demir, Ali Cemal Yumusakhuylu, Asli Sahin Yilmaz, Cagatay Oysu.   

Abstract

OBJECTIVE: The aim of this study is to review the literature about nasal mucociliary clearance (MCC) and passive smoking in otorhinolaryngology by clearly explaining their relationship in a cross-sectional study. STUDY DESIGN AND
SETTING: This cross-sectional study was conducted at the Umraniye Education and Research Hospital in Turkey. Umraniye Education and Research Hospital Ethical Committee approved the study, and informed consents of the patients were obtained.
METHODS: Our study consisted of patients who presented to the Ear-Nose-Throat Department of Istanbul Umraniye Education and Research Hospital between February 2011 and July 2011. Three groups of subjects were evaluated: 15 passive smokers (group 1), 17 active smokers (group 2), and 15 healthy matched controls (group 3). All patients were asked to answer our questions regarding their smoking history, and nasal MCC time was assessed for all individuals of the 3 groups.
RESULTS: The mean MCC value was 23.59 ± 12.41 in the smoking group, 12.6 ± 4.67 in the passive smoking group, and 6.4 ± 1.55 in the healthy group. The comparison of MCC values between the smoking group and passive smoking group and between the smoking group and healthy group revealed statistically significant differences (P < .01). There was also a significant difference between the MCC values of the passive smoking group and the healthy group (P < .01). In addition, we compared MCC values according to exposure number of cigarettes.
CONCLUSION: In this study, we conclude that passive smoking affects nasal MCC. Both active and passive smoking increases nasal MCC time when compared with healthy controls.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22383459     DOI: 10.1177/0194599812439004

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  8 in total

Review 1.  Cilia dysfunction in lung disease.

Authors:  Ann E Tilley; Matthew S Walters; Renat Shaykhiev; Ronald G Crystal
Journal:  Annu Rev Physiol       Date:  2014-10-29       Impact factor: 19.318

Review 2.  Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis and Other Diseases of Mucus Clearance.

Authors:  S Vamsee Raju; George M Solomon; Mark T Dransfield; Steven M Rowe
Journal:  Clin Chest Med       Date:  2015-12-24       Impact factor: 2.878

3.  Does Maras powder affect the nasal mucociliary clearence?

Authors:  İrfan Kara; Omer Faruk Cınar; Adem Doğaner; Muhammed Gazi Yıldız; Saime Sağıroğlu; Nagihan Bilal; Israfil Orhan
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-06-24       Impact factor: 2.503

4.  Diarrhoea and smoking: an analysis of decades of observational data from Bangladesh.

Authors:  Sumon Kumar Das; Mohammod Jobayer Chisti; A M Shamsir Ahmed; Mohammad Abdul Malek; Shahnawaz Ahmed; K M Shahunja; Farzana Ferdous; Fahmida Dil Farzana; Jui Das; Aminur Rahman; Abdullah Al Mamun; Abu Syed Golam Faruque
Journal:  BMC Public Health       Date:  2015-07-12       Impact factor: 3.295

5.  The effects of smoking and smoking cessation on nasal mucociliary clearance, mucus properties and inflammation.

Authors:  Daniela Mitiyo Odagiri Utiyama; Carolina Tieko Yoshida; Danielle Miyuki Goto; Tômas de Santana Carvalho; Ubiratan de Paula Santos; Andreas Rembert Koczulla; Paulo Hilário Nascimento Saldiva; Naomi Kondo Nakagawa
Journal:  Clinics (Sao Paulo)       Date:  2016-07       Impact factor: 2.365

6.  Olfactory dysfunction in passive vs active smoking.

Authors:  Senem Çengel Kurnaz; Emel Tahir; Esra Kavaz
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-09-24

Review 7.  The Mucoadhesive Nanoparticle-Based Delivery System in the Development of Mucosal Vaccines.

Authors:  Kai Zhao; Yinzhuo Xie; Xuezheng Lin; Wei Xu
Journal:  Int J Nanomedicine       Date:  2022-09-28

8.  Effects of oral isotretinoin therapy on the nasal cavities.

Authors:  Hamdi Tasli; Aslan Yurekli; Mert Cemal Gokgoz; Omer Karakoc
Journal:  Braz J Otorhinolaryngol       Date:  2018-11-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.